- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Behavioral Health Quality Trends Affecting Payers

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Behavioral Health Quality Trends Affecting Payers
The evolving trends of mental healthcare quality measures have a marked impact on payers. Join Molly Burich and Madeline Shurtleff in this discussion that will review current behavioral health quality measures, social determinations of health, and the outcome each has on payers.

Molly Burich, (OPDC)
Senior Director, Reimbursement & Health Policy, Government Affairs, Otsuka America Pharmaceutical, Inc.

Madeline Shurtleff, PharmD
Managed Market Liaison
More
Molly Burich & Madeline Shurtleff are employees of Otsuka American Pharmaceutical Development & Commercialization, Inc. (OPDC)